Chronic Disease Mobile Educational Experience
12 september 2019 uppdaterad av: Los Angeles County Department of Public Health
Chronic Disease Mobile Educational Experience for Hospitalized Patients
This study evaluates the effectiveness of a mobile health education module, in increasing hospitalized patients' understanding of their chronic illness, and in reducing 30-day hospital readmission rates.
Half of the participants will receive the educational module intervention in addition to standard education, the other half will receive hospital standard practice education only.
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Chronic disease is the leading cause of death and disability, costing the US healthcare system 1 trillion dollars annually. Successful management of these conditions critically requires patient understanding and engagement. Patients are advised to adhere to medications, redesign lifestyles, and navigate the health care system. Most of these care plan items require careful instruction and confirmation of shared understanding.
Mobile health technology has the potential to assist greatly with patient education, especially for hospitalized patients. This prospective study evaluates a specific mobile technology intervention, an educational and emotionally-engaging video patients watch while admitted for a complication related to one of these chronic diseases: Heart Failure, Diabetes, COPD, Asthma, Cirrhosis, Atrial Fibrillation, Hypertension.
Studietyp
Interventionell
Inskrivning (Förväntat)
200
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
21 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- admission to medical service primary team for decompensation or complication of chronic disease.(e.g. heart failure)
Exclusion Criteria:
- cognitive disability or visual/auditory limitation that prevents self-interaction with educational module
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Educational Module Intervention
Intervention arm patients receive educational mobile module related to chronic condition that contributed to reason for admission.
|
Intervention is interactive, mobile (tablet-or-smart-phone delivered), educational module that patients engage with during hospital admission.
|
|
Inget ingripande: Hospital Practice Control
Control arm patients receive current, standard practice as related to patient education in the hospital (this does not include an educational mobile module).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
30-Day hospital readmission rate
Tidsram: 9 months (270 days)
|
In this study, 30-Day hospital readmission rate is defined as the ratio of patients discharged from LAC+USC Medical Center who are readmitted to either LAC+USC Medical Center or one of three other LA County Department of Health Services (DHS) hospitals.
(These are Olive View Medical Center, Rancho Los Amigos Hospital, and Harbor-UCLA Medical Center).
This rate can be calculated readily by either of two different means: programmed data extraction from the common electronic health record (there is a Power Insight-Cerner report that does this); or blinded, manual chart review.
|
9 months (270 days)
|
|
Self-reported quality of life: Short Form (36) Health Survey
Tidsram: 9 months (270 days)
|
As part of the Medical Outcomes Study (MOS), a multi-year, multi-site study to explain variations in patient outcomes, RAND developed the 36-Item Short Form Health Survey (SF-36).
SF-36 is a set of generic, coherent, and easily administered quality-of-life measures.
These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Survey is attached to this submission.
|
9 months (270 days)
|
|
Patient understanding of chronic disease: 8-item disease focused survey.
Tidsram: 9 months (270 days)
|
This study's authors have developed an 8-item survey, each question with equal rate, designed to measure patients' understanding of several key concepts related to their diagnosis and management.
The higher the score, the better the presumed understanding.
Survey for heart failure is attached to this submission.
|
9 months (270 days)
|
|
Patient satisfaction with treatment: Client Satisfaction Questionnaire (CSQ-8)
Tidsram: 9 months (270 days)
|
The CSQ-8 is an 8-item, easily scored and administered measurement that is designed to measure client satisfaction with services.
The items for the CSQ-8 were selected on the basis of ratings by mental health professionals of a number of items that could be related to client satisfaction and by subsequent factor analysis.
The CSQ-8 is unidimensional, yielding a homogeneous estimate of general satisfaction with services.
The higher the score, the better the presumed patient satisfaction with services.
Survey is attached to this submission.
|
9 months (270 days)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Josh Banerjee, MD, MPH, MS, LAC+USC Medical Center
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Förväntat)
1 september 2019
Primärt slutförande (Förväntat)
1 juni 2020
Avslutad studie (Förväntat)
1 oktober 2020
Studieregistreringsdatum
Först inskickad
13 augusti 2019
Först inskickad som uppfyllde QC-kriterierna
12 september 2019
Första postat (Faktisk)
16 september 2019
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
16 september 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
12 september 2019
Senast verifierad
1 september 2019
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HS-19-00145
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Nej
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .